International Consensus Guidance for Management of Myasthenia Gravis: 2020 Update
Autor
Narayanaswami, Pushpa
Sanders, Donald B.
Wolfe, Gil I.
Benatar, Michael G.
Cea, Gabriel
Evoli, Amelia
Gilhus, Nils Erik
Illa, Isabel
Kuntz, Nancy L.
Massey, Janice M.
Melms, Arthur
Murai, Hiroyuki
Nicolle, Michael W.
Palace, Jacqueline A.
Richman, David
Verschuuren, Jan J.G.M.
Resumen
OBJECTIVE: To update the 2016 formal consensus-based guidance for the management of myasthenia gravis (MG) based on the latest evidence in the literature. METHODS: In October 2013, the Myasthenia Gravis Foundation of America appointed a Task Force to develop treatment guidance for MG, and a panel of 15 international experts was convened. The RAND/UCLA appropriateness method was used to develop consensus recommendations pertaining to 7 treatment topics. In February 2019, the international panel was reconvened with the addition of one member to represent South America. All previous recommendations were reviewed for currency, and new consensus recommendations were developed on topics that required inclusion or updates based on the recent literature. Up to 3 rounds of anonymous e-mail votes were used to reach consensus, with modifications to recommendations between rounds based on the panel input. A simple majority vote (80% of panel members voting "yes") was used to approve minor changes in grammar and syntax to improve clarity. RESULTS: The previous recommendations for thymectomy were updated. New recommendations were developed for the use of rituximab, eculizumab, and methotrexate as well as for the following topics: early immunosuppression in ocular MG and MG associated with immune checkpoint inhibitor treatment. CONCLUSION: This updated formal consensus guidance of international MG experts, based on new evidence, provides recommendations to clinicians caring for patients with MG worldwide.
Colecciones
Ítems relacionados
Mostrando ítems relacionados por Título, autor o materia.
-
Article
Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021 (2024)
Ong, Kanyin Liane; Stafford, Lauryn K.; McLaughlin, Susan A.; Boyko, Edward J.; Vollset, Stein Emil; Smith, Amanda E.; Dalton, Bronte E.; Duprey, Joe; Cruz, Jessica A.; Hagins, Hailey; ... (Elsevier B.V., 2023)Background: Diabetes is one of the leading causes of death and disability worldwide, and affects people regardless of country, age group, or sex. Using the most recent evidentiary and analytical framework from the Global ... -
Article
Global investments in pandemic preparedness and COVID-19: development assistance and domestic spending on health between 1990 and 2026 (2024)
Micah, Angela E.; Bhangdia, Kayleigh; Cogswell, Ian E.; Lasher, Dylan; Lidral-Porter, Brendan; Maddison, Emilie R.; Nguyen, Trang Nhu Ngoc; Patel, Nishali; Pedroza, Paola; Solorio, Juan; ... (Elsevier Ltd, 2023)Background: The COVID-19 pandemic highlighted gaps in health surveillance systems, disease prevention, and treatment globally. Among the many factors that might have led to these gaps is the issue of the financing of ... -
Article
Hidden demographic impacts of fishing and environmental drivers of fecundity in a sea turtle population (2024)
Roast, Michael J.; Martins, Samir; Fernández-Peralta, Lourdes; Báez, José Carlos; Diame, Ahmed; March, David; Ouled-Cheikh, Jazel; Marco, Adolfo; González-Solís, Jacob; Cardona, Luis (John Wiley and Sons Inc, 2023)Fisheries bycatch is a critical threat to sea turtle populations worldwide, particularly because turtles are vulnerable to multiple gear types. The Canary Current is an intensely fished region, yet there has been no ...